OBJECTIVE: To examine whether there are sex-specific associations between brain magnetic resonance imaging (MRI) measures and neuropsychologic (NP) test performance. BACKGROUND: Differences in cardiovascular risk factors have been linked to decreased total cerebral brain volume and white matter hyperintensities (WMHs). Although brain morphology has been related to cognitive performance, few studies have addressed sex-specific effects in this relationship. METHODS: Framingham Offspring who were stroke and dementia-free underwent a brain MRI scan and NP testing (n=2085; 978 men). Factor analysis identified 4 domain-specific NP factors. MRI participants were divided into 4 MRI subgroups based on measures of total cerebral brain volume and combinations of the presence of WMH and silent cerebral infarcts (> or =3 mm). RESULTS: Overall, the relationship between MRI and NP measures was similar between the sexes. The exception was that only men showed a positive relationship between executive function and cerebrovascular disease defined as large WMH volume plus silent cerebral infarct. This finding was attributed only among men with Framingham Stroke Risk Profile scores >90th percentile range (P=0.0019). CONCLUSIONS: Measures of brain atrophy and subclinical markers of vascular disease showed that sex does not significantly alter the relationship between MRI and NP, except among men and women who are at high risk for stroke; these men show poorer performance on executive function, whereas the women do not.
OBJECTIVE: To examine whether there are sex-specific associations between brain magnetic resonance imaging (MRI) measures and neuropsychologic (NP) test performance. BACKGROUND: Differences in cardiovascular risk factors have been linked to decreased total cerebral brain volume and white matter hyperintensities (WMHs). Although brain morphology has been related to cognitive performance, few studies have addressed sex-specific effects in this relationship. METHODS: Framingham Offspring who were stroke and dementia-free underwent a brain MRI scan and NP testing (n=2085; 978 men). Factor analysis identified 4 domain-specific NP factors. MRI participants were divided into 4 MRI subgroups based on measures of total cerebral brain volume and combinations of the presence of WMH and silent cerebral infarcts (> or =3 mm). RESULTS: Overall, the relationship between MRI and NP measures was similar between the sexes. The exception was that only men showed a positive relationship between executive function and cerebrovascular disease defined as large WMH volume plus silent cerebral infarct. This finding was attributed only among men with Framingham Stroke Risk Profile scores >90th percentile range (P=0.0019). CONCLUSIONS: Measures of brain atrophy and subclinical markers of vascular disease showed that sex does not significantly alter the relationship between MRI and NP, except among men and women who are at high risk for stroke; these men show poorer performance on executive function, whereas the women do not.
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; John K Hald; Rhoda Au; Carlos S Kase; Joseph M Massaro; Charles DeCarli Journal: Stroke Date: 2004-05-20 Impact factor: 7.914
Authors: Merrill F Elias; Lisa M Sullivan; Ralph B D'Agostino; Penelope K Elias; Alexa Beiser; Rhoda Au; Sudha Seshadri; Charles DeCarli; Philip A Wolf Journal: Stroke Date: 2004-01-15 Impact factor: 7.914
Authors: Jan Heeringa; Deirdre A M van der Kuip; Albert Hofman; Jan A Kors; Gerard van Herpen; Bruno H Ch Stricker; Theo Stijnen; Gregory Y H Lip; Jacqueline C M Witteman Journal: Eur Heart J Date: 2006-03-09 Impact factor: 29.983
Authors: Tom Jeerakathil; Philip A Wolf; Alexa Beiser; Joseph Massaro; Sudha Seshadri; Ralph B D'Agostino; Charles DeCarli Journal: Stroke Date: 2004-06-24 Impact factor: 7.914
Authors: Berneet Kaur; Jayandra J Himali; Sudha Seshadri; Alexa S Beiser; Rhoda Au; Ann C McKee; Sanford Auerbach; Philip A Wolf; Charles S DeCarli Journal: Alzheimer Dis Assoc Disord Date: 2014 Jul-Sep Impact factor: 2.703
Authors: Eseosa T Ighodaro; Erin L Abner; David W Fardo; Ai-Ling Lin; Yuriko Katsumata; Frederick A Schmitt; Richard J Kryscio; Gregory A Jicha; Janna H Neltner; Sarah E Monsell; Walter A Kukull; Debra K Moser; Frank Appiah; Adam D Bachstetter; Linda J Van Eldik; Peter T Nelson Journal: J Cereb Blood Flow Metab Date: 2016-01-06 Impact factor: 6.200
Authors: Joost A Agelink van Rentergem; Nathalie R de Vent; Ben A Schmand; Jaap M J Murre; Janneke P C Staaks; Hilde M Huizenga Journal: Neuropsychol Rev Date: 2020-02-01 Impact factor: 7.444
Authors: Joel Salinas; Adrienne O'Donnell; Daniel J Kojis; Matthew P Pase; Charles DeCarli; Dorene M Rentz; Lisa F Berkman; Alexa Beiser; Sudha Seshadri Journal: JAMA Netw Open Date: 2021-08-02
Authors: Joel Salinas; Alexa S Beiser; Jasmeet K Samra; Adrienne O'Donnell; Charles S DeCarli; Mitzi M Gonzales; Hugo J Aparicio; Sudha Seshadri Journal: Neurology Date: 2022-02-07 Impact factor: 9.910